SpyGlass Pharma
SGP20.8201.61% ( +0.330 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: SpyGlass Pharma(SGP) predict that the EBIT is -15.41 M (--%), Miss estimate;the EPS is -0.69 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.02B--
-0.01B--
-0.00B--%
EPSMiss expectations
-0.69--
-0.4367--
-0.2533--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf